comparemela.com
Latest Breaking News On - Coalition for hemophiliab we - Page 1 : comparemela.com
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds after up to three years of follow-up, providing sustained bleed protection and.
United-states
Canada
Adam-cuker
Thromb-haemost
Kim-phelan
Aamir-malik
Drug-administration
Linkedin
Pfizer-inc
Hemophilia-thrombosis-program
Facebook
Pfizer
vimarsana © 2020. All Rights Reserved.